Literature DB >> 7795045

Vasculitides associated with infections, immunization, and antimicrobial drugs.

T Somer1, S M Finegold.   

Abstract

Many pathogenic microbes can induce a complex series of immunologic, endothelial-cell, and hemorheological activation cascades and dysfunctions and can cause interactions of various components of the vessel wall with formed and noncellular elements of the blood. These interactions can result in manifold vasculitides. This article reviews the pathogenetic, clinicopathologic, and therapeutic aspects of infection-related vasculitides; it includes a brief discussion of parasitic, drug-related, and immunization-associated vasculitides as well as of the infection-related features of vasculitides of the central nervous system, retinal vasculitides, ecthyma gangrenosum, and erythema nodosum. Viruses are mainly associated with small-vessel vasculitides, whereas bacterial infections affect vessels of all sizes, including the aorta. The vasculitides associated with fungal infection usually are characterized by erythema nodosum and involve large vessels. The search for microbes as causes of or contributors to vasculitides should continue. Infectious vasculitides may become increasingly important as the number of immunocompromised patients grows.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7795045     DOI: 10.1093/clinids/20.4.1010

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  28 in total

1.  Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis.

Authors:  Kum Thong Wong; Wun-Ju Shieh; Shalini Kumar; Karim Norain; Wahidah Abdullah; Jeannette Guarner; Cynthia S Goldsmith; Kaw Bing Chua; Sai Kit Lam; Chong Tin Tan; Khean Jin Goh; Heng Thay Chong; Rani Jusoh; Pierre E Rollin; Thomas G Ksiazek; Sherif R Zaki
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  [Leukocytoclastic vasculitis].

Authors:  C Sunderkötter; J Roth; G Bonsmann
Journal:  Hautarzt       Date:  2004-08       Impact factor: 0.751

Review 3.  Infectious serologies and autoantibodies in hepatitis C and autoimmune disease-associated mixed cryoglobulinemia.

Authors:  Merav Lidar; Noga Lipschitz; Nancy Agmon-Levin; Pnina Langevitz; Ori Barzilai; Maya Ram; Bat-Sheba Porat-Katz; Nicola Bizzaro; Jan Damoiseaux; Jan Willem Cohen Tervaert; Salvatore deVita; Stefano Bombardieri; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 4.  Epidemiology of systemic vasculitis.

Authors:  Suzanne E Lane; Richard Watts; David G I Scott
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

5.  Cutaneous leukocytoclastic vasculitis associated with mycobacterial and salmonella infection.

Authors:  Sulaiman M Al-Mayouf; Sultan Bahabri; Mahmuod Majeed
Journal:  Clin Rheumatol       Date:  2006-10-05       Impact factor: 2.980

6.  Acute childhood encephalitis and meningoencephalitis: Diagnosis and management.

Authors:  E L Ford-Jones; D Macgregor; S Richardson; F Jamieson; S Blaser; H Artsob
Journal:  Paediatr Child Health       Date:  1998-01       Impact factor: 2.253

Review 7.  Severe strongyloidiasis and systemic vasculitis: comorbidity, association or both? Case-based review.

Authors:  Rada Miskovic; Aleksandra Plavsic; Jasna Bolpacic; Sanvila Raskovic; Jovan Ranin; Mirjana Bogic
Journal:  Rheumatol Int       Date:  2018-10-23       Impact factor: 2.631

8.  Detection of Fcgamma receptors on human endothelial cells stimulated with cytokines tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma).

Authors:  L F Pan; R A Kreisle; Y D Shi
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

Review 9.  Eosinophilic Granulomatosis With Polyangiitis: Newer Therapies.

Authors:  Erika P Navarro-Mendoza; Gabriel J Tobón
Journal:  Curr Rheumatol Rep       Date:  2018-04-02       Impact factor: 4.592

Review 10.  [Therapy of vasculitides and vasculopathies].

Authors:  C Sunderkötter; K de Groot
Journal:  Hautarzt       Date:  2008-05       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.